The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects with suspected Glioblastoma brain tumors
- Investigator
- Justin D Hilliard
- Status
- Accepting Candidates
- Ages
- 18 Years - 80 Years
- Sexes
- All